Bode B P, Reuter N, Conroy J L, Souba W W
Division of Surgical Oncology, Massachusetts General Hospital, Boston, USA.
Surgery. 1998 Aug;124(2):260-7; discussion 267-8.
Human hepatoma cells extract glutamine at rates severalfold greater than normal hepatocytes through a high-affinity transporter encoded by the ATB0 gene, which contains two putative phosphorylation sites for protein kinase C (PKC). The studies presented here were undertaken to determine whether System B0-mediated glutamine uptake regulates hepatoma growth and whether PKC regulates the activity of this transporter.
SK-Hep cells were treated with the PKC activator phorbol 12-myristate 13-acetate (PMA) and the initial-rate transport of glutamine and other nutrients measured at specific times thereafter. Growth rates were monitored during culture +/- PMA or an excess of system B0 substrates relative to glutamine.
PMA treatment exerted a rapid (half-life approximately 15 minutes) concentration-dependent inhibition of glutamine uptake rates to 50% of control values via a posttranslational mechanism that decreased transporter maximum velocity. This effect persisted after 24 hours and was abrogated by the PKC inhibitor staurosporine. PMA also significantly decreased amino acid transport System y+ and System L activities but no System A. Chronic treatment with PMA (PKC depletion) inhibited SK-Hep growth, as did attenuation of System B0-mediated glutamine uptake with other B0 substrates.
System B0-mediated glutamine uptake regulates hepatoma cell growth, whereas PKC influences both processes.
人类肝癌细胞通过由ATB0基因编码的高亲和力转运体摄取谷氨酰胺的速率比正常肝细胞高几倍,该基因含有两个假定的蛋白激酶C(PKC)磷酸化位点。本文进行的研究旨在确定系统B0介导的谷氨酰胺摄取是否调节肝癌生长以及PKC是否调节该转运体的活性。
用PKC激活剂佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)处理SK-Hep细胞,并在之后的特定时间测量谷氨酰胺和其他营养物质的初始速率转运。在培养过程中监测生长速率,添加或不添加PMA,或相对于谷氨酰胺添加过量的系统B0底物。
PMA处理通过降低转运体最大速度的翻译后机制,对谷氨酰胺摄取速率产生快速(半衰期约15分钟)的浓度依赖性抑制,使其降至对照值的50%。这种作用在24小时后持续存在,并被PKC抑制剂星形孢菌素消除。PMA还显著降低了氨基酸转运系统y+和系统L的活性,但对系统A没有影响。用PMA长期处理(PKC耗竭)抑制了SK-Hep的生长,用其他B0底物减弱系统B0介导的谷氨酰胺摄取也有同样的效果。
系统B0介导的谷氨酰胺摄取调节肝癌细胞生长,而PKC影响这两个过程。